ReportWire

Tag: genetic counseling

  • Northwell opens a $14M women’s cancer center in New Hyde Park | Long Island Business News

    [ad_1]

    New Hyde Park is now home to a $14 million, 21,000-square-foot for women.

    Northwell Cancer Institute’s Center for Women’s Cancer at the R.J. Zuckerberg Cancer Center offers comprehensive breast and gynecological cancer services. The new facility is designed to provide specialized, integrated care through all stages of treatment and long-term follow-up, and in one location, easing logistical travel burdens.

    The center aims to close a gap in cancer care for women by aligning breast and gynecologic oncology services to incorporate shared genetic and clinical characteristics, particularly in patients with variants and other hereditary cancers.

    “This new center represents our commitment to and the recognition that women’s cancers require specialized, coordinated care,” Dr. Richard Barakat, physician-in-chief and executive director of the Northwell Cancer Institute, said in a news release about the center.

    “By unifying our expertise in breast and gynecologic malignancies, we’re not just enhancing convenience — we’re creating a new approach where genetic counseling, surgical intervention, medical therapy and psychosocial support come together seamlessly, ultimately improving survival rates and quality of life for our patients,” Barakat said.

    The center opens at a time when there are about 311,000 new invasive cases and 117,000 new cases each year in the United States, according to estimates released in 2024 by the American Cancer Society.

    By integrating breast surgery, gynecologic oncology, medical oncology and comprehensive support services, the center aims to address the interconnected nature of women’s cancer risks, offering care tailored to women’s specific health needs.

    Designed by Boston-based E4H Architecture, the center features 26 exam rooms, 10 consultation rooms, two procedure rooms, an onsite laboratory and a therapeutic garden designed to promote relaxation and support wellness. Accessible services include infusion therapy, radiation medicine, plastic surgery, genetic counseling, genomic testing, imaging and – all of which are steps away within the same building.

    The center links the Northwell Cancer Institute and the health system’s Katz Institute for Women’s Health. More than 20 physicians and multidisciplinary teams will collaborate daily, according to established clinical practices that enable real-time care planning and accelerated treatment protocols.

    “The center makes it easier for us to develop care plans with our colleagues and manage our patients as one team,” Dr. Veena John, system head for gynecologic medical oncology at the Northwell Cancer Institute and medical director for the Center for Women’s Cancer, said in the news release.

    “Whether it is a medical oncology trial, a radiation medicine trial or a surgical trial, they will all be available to patients in the same building, limiting the need to go to different sites to enroll,” John added. “Particularly for patients with recurrent disease, we have ongoing trials that offer unique therapies that are otherwise not available, and we expect that the number of trial opportunities will continue to grow.”

    Nurse navigators can coordinate care and guide patients through consultation, treatment and survivorship. Navigators collectively speak nine languages, including Armenian, Cantonese, Hindi and Spanish.


    [ad_2]

    Adina Genn

    Source link

  • JScreen Honors February as National Cancer Prevention Month

    JScreen Honors February as National Cancer Prevention Month

    [ad_1]

    Press Release


    Feb 15, 2022

    JScreen, a national non-profit public health initiative dedicated to preventing genetic diseases, announces its participation in National Cancer Prevention Month in February of 2022. JScreen is focused on raising awareness about hereditary cancers and works in association with Emory University’s Department of Human Genetics to make cancer genetic testing affordable and accessible. To do this, JScreen offers its CancerGEN test: an easy, at-home saliva test that screens for genetic risks for many types of cancer. The mission of JScreen is to ensure healthy futures through genetic testing and education, and it will be stepping up that mission this February.

    The pandemic has made clear to everyone the importance of healthcare and taking preventative measures against disease. With the majority of Cancer Awareness Months occurring in the fall, such as Breast Cancer in October, and Prostate and Ovarian Cancer in September, JScreen emphasizes the importance of maintaining the same level of awareness year-round. CancerGEN, JScreen’s cancer genetic test, analyzes more than 60 cancer susceptibility genes associated with hereditary risks for breast, ovarian, prostate, colorectal, skin, and many other cancers. If a person tests positive, they are able to take action for the prevention or early detection of associated cancers. By providing convenient, at-home access to cutting-edge genetic testing technology, education, and genetic counseling services, JScreen strives to minimize the incidence of hereditary cancers and helps to ensure bright and healthy futures.

    “We understand the financial challenges and accessibility issues facing many Americans,” says Hillary Regelman, Director of National Outreach and Marketing at JScreen. “We know from statistics that half of all men and a third of all women will develop cancer at some point in their lives. We are working toward a future where those numbers aren’t quite so staggering, and that starts with awareness and eliminating barriers to genetic testing.”

    Getting tested through JScreen is easy. All one has to do to receive the simple at-home test is to sign up online. The person will then provide a saliva sample and use the pre-paid postage to mail it in (JScreen was quarantine-friendly even before the pandemic). JScreen’s tests use state-of-the-art genetic sequencing technology to ensure highly accurate results. The robust cancer testing panel includes genes that are actionable, meaning something can be done to help prevent cancer if a person tests positive. JScreen provides results in three weeks or less. A unique feature of JScreen’s process is that it provides access to licensed genetic counselors who provide consults via phone or secure video conferencing to ensure that people understand their results.

    In addition to their CancerGEN test, JScreen offers ReproGEN, a reproductive carrier screening test that gives prospective parents information about the risk of genetic diseases in their future children so they can plan for the health of their families. 

    As a not-for-profit home education and genetic screening program, one of JScreen’s goals is to make testing affordable. With insurance, CancerGEN costs $199 and ReproGEN costs $149, and genetic counseling is included. JScreen offers need-based financial assistance for qualifying individuals.

    The proof of JScreen’s passion for saving lives is in the incredible stories they hear, the healthy babies that are born, and the people who now take action to avoid future cancer diagnoses. As the team at JScreen likes to say: “We are a small team with a huge footprint.”

    Media Contact:

    Hayden Hammerling

    973.405.4600

    hayden@bendergrouppr.com

    Source: JScreen

    [ad_2]

    Source link